Literature DB >> 18259080

Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.

Vincenzo Vincenti1, Enrico Pasanisi, Maurizio Guida, Giuseppe Di Trapani, Mario Sanna.   

Abstract

OBJECTIVE: We aimed to evaluate and compare the auditory performance of neurofibromatosis type 2 (NF2) patients with bilateral total deafness fitted with cochlear or auditory brainstem implants. PATIENTS AND METHODS: A retrospective case review was performed. Nine patients suffering from NF2 who underwent hearing rehabilitation by means of cochlear (4 patients) or auditory brainstem (5 patients) implantation participated in the study. Postoperative auditory performance was assessed using closed- and open-set tests.
RESULTS: In the group of patients fitted with a cochlear implant, 3 subjects achieved open-set speech recognition abilities comparable to those of standard adult postlingual implant patients; the remaining patient scored 0% in all open-set format tests, reporting benefits only in environmental sound detection and lip-reading. Among the 5 patients who underwent auditory brainstem implantation, 1 reached good open-set speech recognition skills, scoring 70% in the common phrases comprehension test, and she was able to communicate on the telephone. Two other patients achieved open-set speech understanding (respectively, 33 and 41% in the common phrases comprehension test), reporting daily use of their device. The remaining 2 patients did not achieve any level of open-set speech perception, obtaining only improved access to environmental sound and lip-reading skills.
CONCLUSIONS: Our study confirmed literature data reporting that cochlear implantation may offer open-set speech communication in NF2 patients. In this small cohort, cochlear implant patients performed better than auditory brainstem implant patients, even if variability in auditory performance was observed with both devices. More studies are needed in order to clarify the role and reliability of electrophysiological tests in predicting the residual functionality of the cochlear nerve after tumor removal. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18259080     DOI: 10.1159/000115437

Source DB:  PubMed          Journal:  Audiol Neurootol        ISSN: 1420-3030            Impact factor:   1.854


  22 in total

1.  Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.

Authors:  Jaishri O Blakeley; D Gareth Evans; John Adler; Derald Brackmann; Ruihong Chen; Rosalie E Ferner; C Oliver Hanemann; Gordon Harris; Susan M Huson; Abraham Jacob; Michel Kalamarides; Matthias A Karajannis; Bruce R Korf; Victor-Felix Mautner; Andrea I McClatchey; Harry Miao; Scott R Plotkin; William Slattery; Anat O Stemmer-Rachamimov; D Bradley Welling; Patrick Y Wen; Brigitte Widemann; Kim Hunter-Schaedle; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2011-12-02       Impact factor: 2.802

2.  Translabyrinthine Excision of Vestibular Schwannoma with Concurrent Cochlear Implantation: Systematic Review.

Authors:  Nicholas J Thompson; Brendan P O'Connell; Kevin D Brown
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-24

Review 3.  Cochlear implantation after solid organ transplantation: long term results and review of the literature.

Authors:  Filippo Di Lella; Ilaria Iaccarino; Maurizio Negri; Vincenzo Vincenti; Federica Canzano; Andrea Bacciu; Enrico Pasanisi; Maurizio Falcioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-21       Impact factor: 2.503

4.  Cochlear implantation after radiation therapy for acoustic neuroma.

Authors:  Mark S Costello; Justin S Golub; John V Barrord; Luke Pater; Myles L Pensak; Ravi N Samy
Journal:  J Radiosurg SBRT       Date:  2016

5.  Responses of neurons in the feline inferior colliculus to modulated electrical stimuli applied on and within the ventral cochlear nucleus; Implications for an advanced auditory brainstem implant.

Authors:  Douglas McCreery; Kamal Yadev; Martin Han
Journal:  Hear Res       Date:  2018-03-09       Impact factor: 3.208

6.  Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.

Authors:  Nicolas -Xavier Bonne; Rabih Aboukais; Marc Baroncini; Audrey Hochart; Pierre Leblond; Franck Broly; Frédérique Dubrulle; Jean-Paul Lejeune; Christophe Vincent
Journal:  Childs Nerv Syst       Date:  2016-10-04       Impact factor: 1.475

7.  Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.

Authors:  Pamela C Roehm; Jon Mallen-St Clair; Daniel Jethanamest; John G Golfinos; William Shapiro; Susan Waltzman; J Thomas Roland
Journal:  J Neurosurg       Date:  2011-07-15       Impact factor: 5.115

Review 8.  The emerging role of hearing loss rehabilitation in patients with vestibular schwannoma treated with Gamma Knife radiosurgery: literature review.

Authors:  Carlotta Morselli; N Boari; M Artico; M Bailo; L O Piccioni; I Giallini; M de Vincentiis; P Mortini; P Mancini
Journal:  Neurosurg Rev       Date:  2020-02-06       Impact factor: 3.042

9.  Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.

Authors:  Luis Lassaletta; Miguel Aristegui; Marimar Medina; Gracia Aranguez; Rosa M Pérez-Mora; Maurizio Falcioni; Javier Gavilán; Paolo Piazza; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-24       Impact factor: 2.503

10.  Cochlear implantation for hearing rehabilitation in single-sided deafness after translabyrinthine vestibular schwannoma surgery.

Authors:  Frederike Hassepass; Susan Arndt; Antje Aschendorff; Roland Laszig; Thomas Wesarg
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.